Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ · Healthcare
Acadia Pharmaceuticals Inc. Operating Income 2009–2025
Acadia Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Acadia Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -4.6 M, a 123.93% decrease year-over-year.
- Acadia Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was 82.8 M, a 324.31% increase year-over-year.
- Acadia Pharmaceuticals Inc. annual operating income for 2025 was 104.8 M, a 54.59% decrease from 2024.
- Acadia Pharmaceuticals Inc. annual operating income for 2024 was 230.8 M, a 414.52% decrease from 2023.
- Acadia Pharmaceuticals Inc. annual operating income for 2023 was -73.4 M, a 67.18% decrease from 2022.
- Acadia Pharmaceuticals Inc. annual operating income for 2022 was -223.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Acadia Pharmaceuticals Inc. Operating Income — FAQ
Acadia Pharmaceuticals Inc. (ACAD) operating income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Acadia Pharmaceuticals Inc.'s operating income?
Acadia Pharmaceuticals Inc. (ACAD) reported operating income of $105M for fiscal 2025.
Where can I see ACAD's operating income history?
The chart and table above show Acadia Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.